Decoy Therapeutics (DCOY) Revenue (2016 - 2026)
Decoy Therapeutics (DCOY) posted quarterly Revenue of $571387.0 for Q2 2021, down 54.04% year-over-year from $1.2 million in Q2 2020, and down 54.97% quarter-over-quarter from $1.3 million in Q1 2021.
Decoy Therapeutics (DCOY) Revenue (2016 - 2026) Analysis & Trends
Decoy Therapeutics (DCOY) has reported Revenue for 6 consecutive years, with $571387.0 the latest figure, recorded in Q2 2021.
- In Q2 2021, Revenue fell 54.04% year-over-year to $571387.0; the TTM figure through Mar 2022 stood at $571387.0 (down 89.36% YoY), while the FY2021 annual figure was $1.8 million, down 64.84% from the prior year.
- Revenue fell to $571387.0 in Q2 2021 per DCOY's latest filing, from $1.3 million in the prior quarter.
- Across five years, Revenue topped out at $1.5 million in Q4 2020 and bottomed at $163067.0 in Q4 2018.
- Historically, Revenue has averaged $714959.6 across 5 years, with a median of $613511.0 in 2019.
- Annual changes were most pronounced in 2019 — Revenue surged 536.97% — and 2021, when it tumbled 54.04%.
- Decoy Therapeutics' Revenue stood at $282828.0 in 2017, then sank by 42.34% to $163067.0 in 2018, then soared by 536.97% to $1.0 million in 2019, then jumped by 42.38% to $1.5 million in 2020, then plunged by 61.36% to $571387.0 in 2021.
- Business Quant data shows DCOY's Revenue at $571387.0 in Q2 2021, $1.3 million in Q1 2021, and $1.5 million in Q4 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 3.33 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 4.29 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 145.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 1.71 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 1.29 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 425.49 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 674.14 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 1.06 Bn |
| 10 | Decoy Therapeutics | 1.82 Mn | 1.82 Mn | - | 227,629.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 227,629.00 |
| Jun 30, 2021 | 571,387.00 |
| Mar 31, 2021 | 1.27 Mn |
| Dec 31, 2020 | 1.48 Mn |
| Sep 30, 2020 | 1.38 Mn |
| Jun 30, 2020 | 1.24 Mn |
| Mar 31, 2020 | 1.13 Mn |
| Dec 31, 2019 | 1.04 Mn |
| Sep 30, 2019 | 874,949.00 |
| Jun 30, 2019 | 895,778.00 |
| Mar 31, 2019 | 655,635.00 |
| Dec 31, 2018 | 163,067.00 |
| Sep 30, 2018 | 469,051.00 |
| Jun 30, 2018 | 245,502.00 |
| Mar 31, 2018 | 178,582.00 |
| Dec 31, 2017 | 282,828.00 |
| Sep 30, 2017 | 413,601.00 |
| Jun 30, 2017 | 335,523.00 |
| Mar 31, 2017 | 242,547.00 |
| Dec 31, 2016 | 291,099.00 |